CLS’s proprietary technology platform is the core of our portfolio of real-time, image-guided laser ablation products for minimally invasive procedures. Our products integrate seamlessly with navigation and imaging platforms, such as MRI and ultrasound, to support high-precision treatment of pathological tissue.
Today, our commercialized portfolio features products with a primary focus on neurosurgery and urology.
Yet the potential extends far beyond these areas as the modular design of our technology platform allows for future adaptation across a wide range of clinical indications.
CLS is continuously exploring adaptations and indications in collaboration with partners across the world.
Prism is our system for neurosurgery; an area that is growing rapidly as the precision and controllability that laser ablation offers really matters for this patient group. Application areas include various diseases caused by pathological tissue in the brain.
Our TRANBERG system is today primarily used for focal laser ablation (FLA) in patients with localized prostate cancer. The procedure is minimally invasive and performed at a urology or radiology department.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region
